Apoptosis and the pathogenesis of IDDM - A question of life and death

被引:133
作者
Mauricio, D
Mandrup-Poulsen, T
机构
[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark
[2] Consorci Hosp Parc Tauli, Endocrine Unit, Sabadell, Spain
关键词
D O I
10.2337/diabetes.47.10.1537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In type 1 diabetes, an immune-mediated process leads to the destruction of pancreatic beta-cells. In the last decade, considerable progress has been made in understanding the cellular and biochemical pathogenic processes of the disease. However, more needs to be learned about the immune mechanisms leading to the development of autoreactive immune cells and the molecular mechanisms of beta-cell death. The study of apoptosis of autoreactive lymphocytes as well as apoptosis of beta-cells may give answers to many still unsolved questions. This review focuses on the possible role of apoptosis both in the regulation of immune mechanisms involved in the pathogenesis of type 1 diabetes and as a way for beta-cells to die. The advancement in the knowledge of the possible role of apoptosis and its regulation in the pathogenesis of type I diabetes may provide new therapeutic tools for the prevention of the disease.
引用
收藏
页码:1537 / 1543
页数:7
相关论文
共 75 条
  • [1] NICOTINAMIDE PREVENTS INTERLEUKIN-1 EFFECTS ON ACCUMULATED INSULIN RELEASE AND NITRIC-OXIDE PRODUCTION IN RAT ISLETS OF LANGERHANS
    ANDERSEN, HU
    JORGENSEN, KH
    EGEBERG, J
    MANDRUPPOULSEN, T
    NERUP, J
    [J]. DIABETES, 1994, 43 (06) : 770 - 777
  • [2] INTERLEUKIN-1 BETA-INDUCED NITRIC-OXIDE PRODUCTION ACTIVATES APOPTOSIS IN PANCREATIC RINM5F CELLS
    ANKARCRONA, M
    DYPBUKT, JM
    BRUNE, B
    NICOTERA, P
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 213 (01) : 172 - 177
  • [3] CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243
  • [4] NICOTINAMIDE AND DEXAMETHASONE INHIBIT INTERLEUKIN-1-INDUCED NITRIC-OXIDE PRODUCTION BY RINM5F CELLS WITHOUT DECREASING MESSENGER-RIBONUCLEIC-ACID EXPRESSION FOR NITRIC-OXIDE SYNTHASE
    CETKOVICCVRLJE, M
    SANDLER, S
    EIZIRIK, DL
    [J]. ENDOCRINOLOGY, 1993, 133 (04) : 1739 - 1743
  • [5] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24
  • [6] MASSIVE UP-REGULATION OF THE FAS LIGAND IN LPR AND GLD MICE - IMPLICATIONS FOR FAS REGULATION AND THE GRAFT-VERSUS-HOST DISEASE-LIKE WASTING SYNDROME
    CHU, JL
    RAMOS, P
    ROSENDORFF, A
    NIKOLICZUGIC, J
    LACY, E
    MATSUZAWA, A
    ELKON, KB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 393 - 398
  • [7] COHEN JJ, 1991, ADV IMMUNOL, V50, P55
  • [8] COHEN JJ, 1994, J LAB CLIN MED, V124, P761
  • [9] COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
  • [10] COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.iy.10.040192.001411